Physician profile
Luis Soruco
NPI 1013065556
$26,785.28
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $11K · 2022: $13.59.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20,390.42 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,240.06 | 2019-2020 | |
| Novo Nordisk INC | $342.15 | 2019-2020 | |
| Abbott Laboratories | $174.07 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $172.96 | 2019-2020 | |
| Shire North American Group INC | $169.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $155.64 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $119.68 | 2019 | |
| Amgen INC. | $115.10 | 2019 | |
| Amneal Pharmaceuticals LLC | $94.17 | 2019 | |
| Tandem Diabetes Care, INC. | $87.49 | 2019 | |
| Dexcom, INC. | $80.92 | 2019 | |
| Mannkind Corporation | $58.32 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $57.30 | 2019-2020 | |
| Lifescan, INC. | $46.91 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $46.69 | 2019 | |
| Medtronic Minimed, INC. | $46.20 | 2019 | |
| Abbvie INC. | $43.05 | 2019 | |
| Radius Health, INC. | $35.77 | 2019 | |
| Becton, Dickinson and Company | $32.32 | 2019 | |
| Corcept Therapeutics | $30.75 | 2019 | |
| Alexion Pharmaceuticals, INC. | $29.97 | 2020 | |
| Vivus LLC | $27.18 | 2019 | |
| Opko Pharmaceuticals, LLC | $24.72 | 2019-2020 | |
| Amarin Pharma, INC. | $21.11 | 2019 | |
| Eisai INC. | $20.80 | 2019 | |
| Companion Medical, INC. | $18.95 | 2019 | |
| Antares Pharma, INC. | $17.75 | 2020 | |
| Recordati_rare_diseases_inc. | $16.64 | 2020 | |
| Insulet Corporation | $15.91 | 2019 | |
| Valeritas, INC. | $15.37 | 2019 | |
| Ibsa Pharma INC. | $12.76 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $12.23 | 2019 | |
| Mission Pharmacal Company | $12.02 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Research and ownership
$878.40 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Soruco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.